Literature DB >> 7987309

Coproporphyrinogen oxidase: gene organization and description of a mutation leading to exon 6 skipping.

M H Delfau-Larue1, P Martasek, B Grandchamp.   

Abstract

Genomic clones containing a human coproporphyrinogen oxidase gene, were isolated. DNA sequencing indicates that the human CPX gene spans about 14 kb and consists of seven exons and six introns. Sequences were determined for all the exons, exon-intron junctions and for 800 bp of promoter region. Introns vary in size from 269 bp to 5 kb and they all have consensus sequences at their boundaries. Primer extension and ribonuclease protection experiments revealed multiple transcriptional initiation sites in a region with sequence motifs characteristic of a promoter. The promoter region is GC-rich and contains multiple potential Sp 1 elements, CACCC boxes and potential GATA-1 binding sites. The availability of the CPX genomic sequence allowed us to determine the mutation in a patient with a hereditary coproporphyria. AG to A mutation was found at the last position of exon 6. This mutation results in exon skipping.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7987309     DOI: 10.1093/hmg/3.8.1325

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

1.  Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria.

Authors:  J Lamoril; H Puy; S D Whatley; C Martin; J R Woolf; V Da Silva; J C Deybach; G H Elder
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

2.  Neonatal-Onset Hereditary Coproporphyria: A New Variant of Hereditary Coproporphyria.

Authors:  Kosei Hasegawa; Hiroyuki Tanaka; Miho Yamashita; Yousuke Higuchi; Takayuki Miyai; Junko Yoshimoto; Ayumi Okada; Norihiro Suzuki; Keiji Iwatsuki; Hirokazu Tsukahara
Journal:  JIMD Rep       Date:  2017-03-28

3.  Structural basis of hereditary coproporphyria.

Authors:  Dong-Sun Lee; Eva Flachsová; Michaela Bodnárová; Borries Demeler; Pavel Martásek; C S Raman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-21       Impact factor: 11.205

4.  Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327R.

Authors:  Alev Hasanoglu; Manisha Balwani; Ciğdem S Kasapkara; Fatih S Ezgü; Ilyas Okur; Leyla Tümer; Alpay Cakmak; Irina Nazarenko; Chunli Yu; Sonia Clavero; David F Bishop; Robert J Desnick
Journal:  J Inherit Metab Dis       Date:  2010-11-20       Impact factor: 4.982

5.  Examination of mitochondrial protein targeting of haem synthetic enzymes: in vivo identification of three functional haem-responsive motifs in 5-aminolaevulinate synthase.

Authors:  Tamara A Dailey; John H Woodruff; Harry A Dailey
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 6.  Molecular abnormalities of coproporphyrinogen oxidase in patients with hereditary coproporphyria.

Authors:  B Grandchamp; J Lamoril; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

7.  Cloning, expression, and biochemical properties of CPOX4, a genetic variant of coproporphyrinogen oxidase that affects susceptibility to mercury toxicity in humans.

Authors:  Tingting Li; James S Woods
Journal:  Toxicol Sci       Date:  2009-04-01       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.